Amundi Asset Management US’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-379,326
Closed -$9.86M 1546
2020
Q4
$9.86M Buy
379,326
+29,923
+9% +$896K 0.01% 812
2020
Q3
$13M Sell
349,403
-10,061
-3% -$398K 0.01% 663
2020
Q2
$18.4M Buy
359,464
+41,112
+13% +$1.72M 0.02% 529
2020
Q1
$10M Sell
318,352
-8,446
-3% -$446K 0.02% 561
2019
Q4
$19.5M Buy
326,798
+51,645
+19% +$2.32M 0.02% 574
2019
Q3
$10.1M Buy
275,153
+3,056
+1% +$121K 0.02% 697
2019
Q2
$12.7M Sell
272,097
-1,580
-0.6% -$74.2K 0.01% 723
2019
Q1
$11M Sell
273,677
-384
-0.1% -$17.2K 0.02% 691
2018
Q4
$12.6K Sell
274,061
-69,233
-20% -$3.34M 0.01% 587
2018
Q3
$15.2M Buy
343,294
+22,479
+7% +$1.03M 0.02% 627
2018
Q2
$12.6M Buy
320,815
+26,085
+9% +$1.32M 0.02% 661
2018
Q1
$21.3M Buy
294,730
+56,346
+24% +$4.14M 0.03% 462
2017
Q4
$15.7M Buy
238,384
+48,485
+26% +$2.61M 0.02% 540
2017
Q3
$9.52M Buy
+189,899
New +$9.16M 0.03% 308

Other funds holding ESPR